Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C12H16F3N.ClH |
Molecular Weight | 267.718 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCN[C@H](C)CC1=CC(=CC=C1)C(F)(F)F
InChI
InChIKey=ZXKXJHAOUFHNAS-SBSPUUFOSA-N
InChI=1S/C12H16F3N.ClH/c1-3-16-9(2)7-10-5-4-6-11(8-10)12(13,14)15;/h4-6,8-9,16H,3,7H2,1-2H3;1H/t9-;/m1./s1
LEVOFENFLURAMINE is a levorotatory enantiomer of fenfluramine, a substituted amphetamine which was formerly used to treat obesity. LEVOFENFLURAMINE has dopamine-antagonistic properties and, at high doses, increases dopamine concentrations in rat striatal dialysates. It is essentially inactive to reduce food intake in human subjects.
CNS Activity
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Differential effects of d-fenfluramine, l-fenfluramine and d-amphetamine on the microstructure of human eating behaviour. | 1991 Apr |
|
Effects of fenfluramine and phentermine (fen-phen) on dopamine and serotonin release in rat striatum: in vivo microdialysis study in conscious animals. | 1998 Nov 30 |
|
(+)-Fenfluramine and its major metabolite, (+)-norfenfluramine, are potent substrates for norepinephrine transporters. | 2003 Jun |
|
Medicine as a corporate enterprise, patient welfare centered profession, or patient welfare centered professional enterprise? | 2005 Nov |
|
Off-label promotion, on-target sales. | 2008 Oct 28 |
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DEA NO. |
1670
Created by
admin on Sat Dec 16 09:28:26 GMT 2023 , Edited by admin on Sat Dec 16 09:28:26 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
3616-78-2
Created by
admin on Sat Dec 16 09:28:26 GMT 2023 , Edited by admin on Sat Dec 16 09:28:26 GMT 2023
|
PRIMARY | |||
|
7B013935Z2
Created by
admin on Sat Dec 16 09:28:26 GMT 2023 , Edited by admin on Sat Dec 16 09:28:26 GMT 2023
|
PRIMARY | |||
|
222-803-7
Created by
admin on Sat Dec 16 09:28:26 GMT 2023 , Edited by admin on Sat Dec 16 09:28:26 GMT 2023
|
PRIMARY | |||
|
DTXSID2048872
Created by
admin on Sat Dec 16 09:28:26 GMT 2023 , Edited by admin on Sat Dec 16 09:28:26 GMT 2023
|
PRIMARY | |||
|
16219349
Created by
admin on Sat Dec 16 09:28:26 GMT 2023 , Edited by admin on Sat Dec 16 09:28:26 GMT 2023
|
PRIMARY | |||
|
m5274
Created by
admin on Sat Dec 16 09:28:26 GMT 2023 , Edited by admin on Sat Dec 16 09:28:26 GMT 2023
|
PRIMARY | Merck Index |
SUBSTANCE RECORD